EULAR recommendations for the management of primary small and medium vessel vasculitis

By C. Mukhtyar, L. Guillevin, M. Cid, B. Dasgupta, K. D. Groot, W. Gross, T. Hauser, B. Hellmich, D. Jayne, C. Kallenberg and 10 more. Annals of the Rheumatic Diseases, 2008

974 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/9baac50205dbc87e66c561dd74b03cea099ade9a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Yates
2. R. Watts
3. I. Bajema
4. O. Flossmann
5. A. Berden
6. T. Hauser
7. J. Holle
8. B. Crestani

Citations in the corpus

• Long-term patient survival in ANCA-associated vasculitis (2010, background): “The past 20 years has seen the advent of randomised therapeutic trials in ANCA-associated vasculitis, which have substantially contributed to establishing modern treatment paradigms in these diseases.”
• EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (2016, methodology): “8 The number of evaluated manuscripts is described and presented as a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram, see Figure 1 (separate file) (10).”
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue (2019, neutral): “References [105–127]”